Antithymocyte globulins suppress dendritic cell function by multiple mechanisms

Transplantation

Volumn 83, Issue 4, 2007, Pages 485-497

  Naujokat, Cord ^a   Berges, Carsten ^a   Fuchs, Dominik ^a   Sadeghi, Mahmoud ^a   Opelz, Gerhard ^a   Daniel, Volker ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anti T cell immunoglobulins; Cell surface receptors; Dendritic cells; Immunosuppression; T cell stimulation

Indexed keywords

B7 ANTIGEN; CD206 ANTIGEN; CD209 ANTIGEN; CD36 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL SURFACE RECEPTOR; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P70; LECTIN; LYMPHOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P50; PROTEIN P52; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR REL;

ALLOGRAFT; ANTIGEN BINDING; APOPTOSIS; ARTICLE; AUTOGRAFT; BINDING AFFINITY; CELL FUNCTION; CELL MATURATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DENDRITIC CELL; DRUG BINDING; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; MONOCYTE; PINOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; KINETICS; METABOLISM;

ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; INTERLEUKIN-12; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, ANTIGEN;

EID: 33947500204     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251975.81281.22     Document Type: Article

References (47)

1. Bonnefoy-Berard N, Revillard JP. Mechanisms of immunosuppression by antithymocyte globulins and OKT3. J Heart Lung Transplant 1996; 15: 435.
2. Shapiro R, Young JB, Milford EL, et al. Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant 2005; 5: 874.
3. Bacigalupo A. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects. Bone Marrow Transplant 2005; 35: 225.
4. Genestier L, Fournel S, Flacher M, et al. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 1998; 91: 2360.
5. Merion RM, Howell T, Bromberg JS. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation 1998; 65: 148.
6. Mueller TF. Thymoglobulin: an immunologic overview. Curr Opin Organ Transplant 2003; 8: 305.
7. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245.
8. Raimondi G, Thomson AW. 2005. Dendritic cells, tolerance and therapy of organ allograft rejection. Contrib Nephrol 2005; 146: 105.
9. Niimi M, Shirasugi N, Ikeda Y, et al. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway. Transplantation 2001; 72: 1556.
10. Liang X, Lu L, Chen Z, et al. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003; 76: 721.
11. Tiao MM, Lu L, Tao R, et al. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg 2005; 241: 497.
12. Faries MB, Bedrosian I, Xu S, et al. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood 2001; 98: 2489.
13. Bunn D, Lea CK, Bevan DJ, et al. The pharmacokinetics of anti-thymocyte globulin (ATG) following intravenous infusion in man. Clin Nephrol 1996; 45: 29.
14. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389.
15. Schreiber E, Matthias E, Müller M, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 1989; 17: 641.
16. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995; 59: 1194.
17. Hardinger KL, Schnitzler MA, Miller B, et al. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation 2004; 78: 136.
18. Bock HA, Gallati H, Zürcher RM, et al. A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 1995; 59: 830.
19. Klaus G, Mostert K, Reckzeh B, Müller TF. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion. Transplantation 2003; 76: 1719.
20. Weimer R, Staack A, Süsal C, et al. ATG induction therapy: long-term effects on Th1 but not on Th2 responses. Transpl Int 2005; 18: 226.
21. Vandenabeele S, Hochrein H, Mavaddat N, et al. Human thymus contains 2 distinct dendritic cell populations. Blood 2001; 97: 1733.
22. Schmitt C, Fohrer H, Beaudet S, et al. Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo. J Leukoc Biol 2000; 68: 836.
23. Tenca C, Merlo A, Zarcone D, et al. Death of T cell precursors in the human thymus: a role for CD38. Int Immunol 2003; 15: 1105.
24. Lafontaine M, Landry D, Montplaisir S. Human thymic dendritic cells. Microsc Res Tech 1997; 38: 267.
25. Bonnefoy-Berard N. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51: 669.
26. Rebellato LM, Gross U, Verbanac KM, Thomas JM. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994; 57: 685.
27. Michallet MC, Preville X, Flacher M, et al. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003; 75: 657.
28. De Baey A, Lanzavecchia A. The role of aquaporins in dendritic cell macropinocytosis. J Exp Med 2000; 191: 743.
29. + Valpha24 natural killer T cells expressing CD40L. Immunology 2001;102: 137.
30. Bertho N, Drenou B, Laupeze B, et al. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J Immunol 2000; 164: 2379.
31. Aicher A, Shu GL, Magaletti D, et al. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J Immunol 1999; 163: 5786.
32. Puig-Kroger A, Relloso M, Fernandez-Capetillo O, et al. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001; 98: 2175.
33. Yu Q, Kovacs C, Yue FY, Ostrowski MA. The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses. J Immunol 2004; 172: 6047.
34. Nakagawa S, Ohtani T, Mizuashi M, et al. p38 Mitogen-Activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. J Invest Dermatol 2004; 123: 361.
35. Zhu L, Yu X, Akatsuka Y, et al. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 1999; 97: 26.
36. Rezzonico R, Chicheportiche R, Imbert V, Dayer JM. Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 2000; 95: 3868.
37. Orabona C, Grohmann U, Belladonna ML, et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol 2004; 5: 1134.
38. Neumann M, Fries H, Scheicher C, et al. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000; 95: 277.
39. Rezzonico R, Imbert V, Chicheportiche R, Dayer JM. Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB. Blood 2001; 97: 2932.
40. Kaku H, Horikawa K, Obata Y, et al. NF-kappaB is required for CD38-mediated induction of C(gamma)1 germline transcripts in murine B lymphocytes. Int Immunol 2002; 14: 1055.
41. Saccani S, Pantano S, Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 2002; 3: 69.
42. Luft T, Luetjens P, Hochrein H, et al. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 2002; 14: 367.
43. Fang L, Fehse B, Engel M, et al. Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells. Transplantation 2005; 79: 369.
44. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412.
45. Chan GW, Gorgun G, Miller KB, Foss FM. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170.
46. Kirk AD, Tadaki DK, Celniker A, et al. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 2001; 72: 377.
47. Kwekkeboom J, Tha-In T, Tra WM, et al. Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation. Am J Transplant 2005; 5: 2393.